Early scans for pancreatic cancer to avoid surgery

Tackling the diagnosis and management of pancreatic cancer, NICE has recommended the use of a more accurate scan to diagnose and determine the stage of pancreatic cancer in patients.

Known as PET-CT, the computed tomography (CT) scan is predicted to result in a 20 per cent reduction in surgery to remove the cancer, ensuring those with inoperable cancer can get earlier access to other treatments such as chemotherapy.

Pancreatic cancer is the fifth leading cause of cancer death in the UK, with in excess of 9,500 new cases diagnosed each year. Once diagnosed, life expectancy is usually six months.

Mark Baker, director of the centre for guidelines at NICE, said: “The PET-CT scan could have a significant impact on the treatment of patients with pancreatic cancer. It will mean that the staging process is more effective so that patients stand a better chance of getting the right treatment, at the right time.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho